(Q43978031)

28 November 2017

title

Differential blood pressure effects of oral glucose and intravenous L-arginine in healthy lean normotensive and obese hypertensive subjects (English)

1 reference

28 November 2017

0 references

Castejon AM

1

1 reference

28 November 2017

Hoffmann IS

2

1 reference

28 November 2017

Jimenez E

3

1 reference

28 November 2017

Cubeddu RJ

4

1 reference

28 November 2017

Baldonedo RM

5

1 reference

28 November 2017

Cubeddu LX

6

1 reference

28 November 2017

publication date

1 March 2002

1 reference

Journal of Human Hypertension

28 November 2017

published in

1 reference

28 November 2017

volume

16 Suppl 1

1 reference

28 November 2017

page(s)

S133-6

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001359

28 November 2017

exact match

0 references

cites work

Serum-insulin in essential hypertension and in peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Insulin resistance in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Essential hypertension and insulin resistance in non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Relationship between insulin resistance and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Is insulin resistance linked to hypertension?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Nitric oxide release accounts for insulin's vascular effects in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Relationship between insulin resistance and endothelium-dependent vascular relaxation in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Endothelial dysfunction: cause of the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Additive effects of obesity, hypertension, and type 2 diabetes on insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Role of insulin resistance in the pathogenesis of NIDDM.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Postprandial hyperinsulinemia in patients with mild essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Chronic intravenous glucose infusion causes moderate hypertension in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Renal response to L-arginine in salt-sensitive patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001359

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001359

1 reference

Dimensions Publication ID

28 November 2017

1019721814

0 references

1 reference